Brief: Grand Pharmaceutical Says FDA Approved New Indication Of Sir-Spheres Y-90 Resin Microsphere Injection
07/07/2025 14:02
July 7 (Reuters) - Grand Pharmaceutical 0512.HK: NEW INDICATION OF SIR-SPHERES Y-90 RESIN MICROSPHERE INJECTION APPROVED BY FDA Further company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement